We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STO:ASXSantos Limited Analysis

Data as of 2026-03-13 - not real-time

A$7.53

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Santos Limited (STO) is trading at AUD 7.53, comfortably above its 20‑day (7.09), 50‑day (6.73) and 200‑day (6.99) moving averages, while the RSI sits at 66 and the MACD shows a bullish crossover, indicating short‑term momentum support. Volume is trending upward and the market sentiment index reads 73.34 (Greed), suggesting investors are currently optimistic. However, the DCF‑derived fair value of only AUD 1.35 signals a stark valuation gap, and the company’s revenue has contracted -11.6% year‑over‑year, with a high debt‑to‑equity ratio of 48% and a payout ratio near 93%, raising questions about dividend sustainability. The stock’s 30‑day volatility of 34% and a beta of 0.49 reflect moderate price swings but lower market correlation, while the energy sector faces medium regulatory and geographic risks due to operations in Australia, Papua New Guinea and Timor‑Leste.
Given the blend of strong short‑term technicals, an attractive 4.63% dividend yield, and concerning fundamentals such as declining revenue and elevated leverage, the outlook is mixed: investors may consider a cautious buy for the near term, hold for the medium horizon, and monitor long‑term exposure to energy transition and debt servicing pressures.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above all key moving averages
  • Bullish MACD histogram
  • Increasing trading volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue decline of 11.6%
  • High debt‑to‑equity ratio (48%)
  • Attractive dividend yield but high payout ratio

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Energy transition and regulatory headwinds
  • Strong cash flow but elevated leverage
  • Sustained dividend income potential

Key Metrics & Analysis

Financial Health

Revenue Growth-11.60%
Profit Margin16.56%
P/E Ratio21.5
ROE5.24%
ROA2.35%
Debt/Equity48.13
P/B Ratio1.1
Op. Cash FlowA$2.8B
Free Cash FlowA$745.6M
Industry P/E22.2

Technical Analysis

TrendNeutral
RSI66.3
SupportA$6.42
ResistanceA$7.92
MA 20A$7.09
MA 50A$6.73
MA 200A$6.99
MACDBullish
VolumeIncreasing
Fear & Greed Index73.34

Valuation

Fair ValueA$1.35
Target PriceA$8.08
Upside/Downside7.28%
GradeOvervalued
TypeBlend
Dividend Yield4.63%

Risk Assessment

Beta0.49
Volatility34.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.